SSG
Summit Securities Group Portfolio holdings
AUM
$280M
1-Year Return
13.47%
This Quarter Return
+4.79%
1 Year Return
+13.47%
3 Year Return
+33.41%
5 Year Return
+89.54%
10 Year Return
+225.55%
AUM
$280M
AUM Growth
+$135M
(+94%)
Cap. Flow
+$127M
Cap. Flow
% of AUM
45.49%
Top 10 Holdings %
Top 10 Hldgs %
47.28%
Holding
1,339
New
676
Increased
120
Reduced
110
Closed
382
Top Buys
| 1 |
AZEK
The AZEK Co
AZEK
|
$38.3M |
| 2 |
Invesco QQQ Trust
QQQ
|
$17.3M |
| 3 |
Advanced Micro Devices
AMD
|
$7.1M |
| 4 |
Novo Nordisk
NVO
|
$6.75M |
| 5 |
BP
BP
|
$6.73M |
Top Sells
| 1 |
CME Group
CME
|
$6.38M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$6.02M |
| 3 |
Altria Group
MO
|
$3.59M |
| 4 |
TSMC
TSM
|
$3.58M |
| 5 |
SPDR Dow Jones Industrial Average ETF Trust
DIA
|
$3.44M |
Sector Composition
| 1 | Technology | 19.88% |
| 2 | Industrials | 18.11% |
| 3 | Healthcare | 9.27% |
| 4 | Energy | 7.27% |
| 5 | Consumer Staples | 7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Annaly Capital Management
NLY
$14.2B
| $126K | 0.02% |
6,700
+5,700
| +570% | +$107K |
|
227
Accenture
ACN
$159B
| $126K | 0.02% |
+421
| New | +$126K |
|
228
Builders FirstSource
BLDR
$16.5B
| $125K | 0.02% |
+1,074
| New | +$125K |
|
229
Graco
GGG
$14.2B
| $125K | 0.02% |
+1,453
| New | +$125K |
|
230
Target
TGT
$42.3B
| $125K | 0.02% |
+1,263
| New | +$125K |
|
231
Assured Guaranty
AGO
$3.91B
| $122K | 0.02% |
+1,395
| New | +$122K |
|
232
Kosmos Energy
KOS
$784M
| $120K | 0.02% |
+69,927
| New | +$120K |
|
233
RH
RH
$4.7B
| $120K | 0.02% |
+634
| New | +$120K |
|
234
PepsiCo
PEP
$200B
| $119K | 0.02% |
+900
| New | +$119K |
|
235
Bright Horizons
BFAM
$6.64B
| $118K | 0.02% |
+953
| New | +$118K |
|
236
Cooper Companies
COO
$13.5B
| $116K | 0.02% |
+1,635
| New | +$116K |
|
237
Foot Locker
FL
$2.29B
| $116K | 0.02% |
+4,728
| New | +$116K |
|
238
Ceco Environmental
CECO
$1.72B
| $115K | 0.02% |
4,074
+3,264
| +403% | +$92.4K |
|
239
Chart Industries
GTLS
$8.96B
| $115K | 0.02% |
700
+699
| +69,900% | +$115K |
|
240
Tandem Diabetes Care
TNDM
$850M
| $115K | 0.02% |
+6,160
| New | +$115K |
|
241
Cytek Biosciences
CTKB
$511M
| $113K | 0.02% |
+33,276
| New | +$113K |
|
242
S&P Global
SPGI
$164B
| $111K | 0.02% |
+211
| New | +$111K |
|
243
Cardinal Health
CAH
$35.7B
| $111K | 0.02% |
660
+196
| +42% | +$32.9K |
|
244
Construction Partners
ROAD
$6.87B
| $111K | 0.02% |
1,041
+930
| +838% | +$98.8K |
|
245
Stevanato
STVN
$6.59B
| $109K | 0.02% |
+4,477
| New | +$109K |
|
246
Agilon Health
AGL
$497M
| $108K | 0.02% |
+47,000
| New | +$108K |
|
247
BioLife Solutions
BLFS
$1.27B
| $107K | 0.02% |
+4,978
| New | +$107K |
|
248
Merck
MRK
$212B
| $107K | 0.02% |
+1,353
| New | +$107K |
|
249
Citigroup
C
$176B
| $107K | 0.02% |
1,257
-6,443
| -84% | -$548K |
|
250
Boston Scientific
BSX
$159B
| $107K | 0.02% |
+996
| New | +$107K |
|